Filing Details
- Accession Number:
- 0001209191-19-019459
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-14 16:34:33
- Reporting Period:
- 2019-03-12
- Accepted Time:
- 2019-03-14 16:34:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1640266 | Voyager Therapeutics Inc. | VYGR | Biological Products, (No Disgnostic Substances) (2836) | CA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 914475 | Neurocrine Biosciences Inc | 12780 El Camino Real San Diego CA 92130 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-12 | 4,179,728 | $11.96 | 4,179,728 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase price was determined in accordance with that certain Stock Purchase Agreement dated January 28, 2019 between the reporting person and the issuer.
Billionaire Hedge Funds
